Delivery of miR-16 using an EnGeneIC Delivery Vehicle (EDV) nanocell system targeting epidermal growth factor receptor (EGFR) in NSCLC and malignant pleural mesothelioma resulted in significant tumor reduction [196]. Here, EGFR is linked to neoplasm.